Tachyphylaxis to angiotensin II and [Phe4]-angiotensin II in the rat mesentery in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 13-20

  Tofovic, Stevan P ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN II [4 PHENYLALANINE]; ANGIOTENSIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; MALE; MESENTERY BLOOD FLOW; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REGIONAL PERFUSION; STRUCTURE ACTIVITY RELATION; TACHYPHYLAXIS; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRA-ARTERIAL; MALE; MESENTERIC ARTERIES; RATS; RATS, SPRAGUE-DAWLEY; SPLANCHNIC CIRCULATION; TACHYPHYLAXIS; VASOCONSTRICTION;

EID: 0029878871     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ABDELLATIF, M. M., NEUBAUER, C. F., LEDERER, W. J. AND ROGERS, T.: Angiotensin-induced desensitization of the phosphomositide pathway in cardiac cells occurs at the level of the receptor. Circ. Res. 69: 800-809, 1991.
2. AIKEN, J. W. E.: Effect of prostaglandins synthesis inhibitors on angiotensin tachyphylaxis in the isolated coeliac and mesenteric arteries of the rabbit. Pol. J. Pharmacol. Pharma. 26: 217-227, 1974.
3. BOULAY, G., SERVANT, G., LUONG, T T., ESCHER, E. AND GUILLEMETTE, G.: Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Mol. Pharmacol. 41:809-815, 1992.
4. CHIBA, S. AND TSUKADA, M.: Angiotensin II-induced tachyphylactic constrictions in isolated and perfused canine mesenteric arteries. Tohoku J. Exp. Med. 150: 417-426, 1986.
5. 1b receptors: pharmacological and functional requirements. FEBS Lett. 349: 365-370, 1994.
6. EL-KASHEF, H A., EHRHART, I. C. AND HOFMAN, W. F.: Reversal of tachyphylaxis to angiotensin II in dog lung. Pharmacology 41: 130-140, 1990.
7. FASCIOLO, J. C. AND BINIA, A.: Angiotensin I, II, and III tachyphylaxis in the mesenteric vascular bed circuit of the rat. Hypertension 3: (Suppl. II), II-167-II-170, 1981.
8. GOODFRIEND, T. L.: Physiological effects of angiotensin on the blood vessels and heart. In Handbook of Hypertension, Vol. 8, Pathophysiology of Hypertension - Regulatory Mechanisms, ed. by A. Zaneghetti and R. C. Tarazi, pp. 389-420, Elsevier Science Publishers B. V., Amsterdam, 1986.
9. JACKSON, E. K.: In vivo evaluation of the antagonist activity of angiotensin I. J. Pharmac. Exp. Ther. 260: 223-231, 1991.
10. JACKSON, E. K AND CAMPBELL, W B : The in situ blood perfused rat mesentery: A model for assessing modulation of adrenergic neurotransmission. Eur. J. Pharmacol. 66: 217-224. 1980.
11. JACKSON, E. K., PRAKASH, C. AND BLAIR, I. A.: Studies on the peptides encoded by rat and human angiotensin II complementary RNA. Hypertension 21: 42-49, 1991.
12. JUUL, B. C AND AZALKJAER, M. J.: Responses of femoral resistance vessels to angiotensin in vivo. Eur. J Pharmacol. 135: 61-68, 1987.
13. KHAIRALLAH, P A., PAGE, I. H., BUMPS, F. M. AND TURKEK, R. K: Angiotensin tachyphylaxis and its reversal. Circ. Res 19: 247-254, 1966.
14. KUAN, C.-J., WELLS, J. N. AND JACKSON, E. K.: Endogenous adenosine restrains renin release in conscious rats. Circ. Res. 66: 637-646, 1990.
15. KUTTAN, S. C. AND SIM, M. K.: Angiotensin II-induced tachyphylaxis in aortas of normo- and hypertensive rats: changes in receptor affinity. Eur. J. Pharmacol 232: 173-180, 1993.
16. LEFKOWITZ, E. J., HAUSDORFF, W. P. AND CARON, M G.: Role of phosphorylation in desensitization of the beta-adrenoceptor. Trends Pharmacol. Sci. 11: 190-194, 1990.
17. MIASIRO, N., OSHIRO, M. E. M., PAIVA, T. B. AND PAIVA, A. C. N.: Role of the two N-terminal residues of angiotensin II in the production of tachyphylaxis. Eur. J. Pharmacol. 87: 397-406, 1983.
18. MOORE, G. J.: Designing peptide mimetics. Trends Pharmacol. Sci. 15: 124-129, 1994.
19. MOORE, G. J., FRANKLIN, K. J., NYSTROM, D M. AND GOGHARI, M. H.: Structure-desensitization relationships of angiotensin analogues in the rat isolated uterus Can. J. Pharmacol. 63: 966-971, 1985.
20. MOORE, G. J. AND KHAIRALLAH, P. P. A.: Further studies on angiotensin tachyphylaxis. J. Pharmacol. Exp. Ther. 197: 576-581, 1976.
21. NAVERI, L., STROMBERG, C., SAAVEDRA, J. M.: Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J. Cereb. Blood Flow Metab. 14:1096-1099, 1994.
22. OSEI, S. Y., MINKES, R. K., MELLAN, J. A. AND KADOWITZ, P. J.: Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to Ang II in the feline hindquarters vascular bed. J. Pharmacol. Exp. Ther. 264: 1104-1112, 1993.
23. OSHIRO, M. E. M., MIASIRO, N., PAIVA, T. B. AND PAIVA, A. C. M.: Angiotensin tachyphylaxis in the isolated rabbit aorta. Blood Vessels 21: 72-79, 1984.
24. OSHIRO, M. E. M., SHIMUTA, S. I., PAVIA, T. B. AND PAVIA, A. C. M.: Evidence for a regulatory site in the angiotensin II receptor of smooth muscle. Eur. J. Pharmacol. 166: 411-417, 1989.
25. PAGE, I. H. AND BUMPUS, M.: Angiotensin. Physiol. Rev. 41: 331-390, 1961.
26. PURDY, R. E., PRINS, B. A., WEBER, M. A., BAKHTIARIAN, A., SMITH, J. R., KIM, M. K. AND NGUYEN, T. -H. T.: Possible novel action of oubain: allosteric modulation of vascular serotoninergic (5-HT2) and angiotensinergic (AT1) receptors. J. Pharmacol. Exp. Ther. 267: 228-237, 1993.
27. ROBERTSON, M. J., WRAGG, A. AND CLARK, K. L.: Modulation of tachyphylaxis to angiotensin II in rabbit isolated aorta by the angiotensin AT1 receptor antagonist, losartan. Regul. Peptide 50: 137-145, 1994.
28. SATOH, S., ITOH, T. AND KURIYAMA, H.: Actions of angiotensin II and noradrenaline on smooth muscle cells of the canine mesenteric artery. Pflugers Arch 410: 132-138, 1987.
29. SCHOLTZ, H. AND KURTZ, A.: Role of protein kinase C in renal vasoconstriction caused by angiotensin II. Am. J. Physiol. 259: C421-C426, 1990.
30. SHIMUTA, S. I., NAKAIE, C. R., PAIVA, A. C. M., CORDOPATIS, P. AND THEODOROPOULOS, D.: Changes in residues 1 and 4 of angiotensin II affect differently its agonist and tachyphylactic properties. Naun. Schmied. Arch. Pharmacol 340: 309-313, 1989.
31. 2α on angiotensin induced contraction and tachyphylaxis in rat aortic rings. Pharmacol. Toxicol. 70: 60-64, 1992.
32. SIM, M. K. AND RADHAKRISHNAN, R.: In vivo study of angiotensin II tachyphylaxis in freely moving normo- and hypertensive rats. Pharmac. Toxicol. 74: 223-227, 1994.
33. STEWART, J. M.: Tachyphylaxis to Angiotensin. In Handbook of Experimental Pharmacology Vol. 37: Angiotensin, ed. by I H. Page and F. M. Bumpus, pp. 170-184, Springer-Verlag, New York, 1974.
34. SWANSON, G. N., HANESWORTH, J. M., SARDINIA, M. F., COLEMAN, J. K. M., WRIGHT, J. W., HALL, K. L., MILLER-WING, A. V., STOBB, J. W., COOK, V. I. AND HARDING, E. C.: Discovery of a distinct bingding site for angiotensin II (3-8), a putative angiotensine IV receptors. Regul. Peptide 40: 409-419, 1992.
35. TOFOVIC, S. P., PONG, A. S. AND JACKSON, E. K.: Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats. Hypertension 18: 774-782, 1991.
36. ULLIAN, M. E. AND LINAS, S. L.: Angiotensin II surface receptor coupling to inositol triphosphate formation in vascular smooth muscle cells. J. Biol. Chem. 265: 195-200, 1990.
37. YOSHIDA, K., YAMAZAKI, M. AND TODA, N.: Different modulation by cyclooxygenase inhibitors of the response to angiotensin II in monkey arteries and veins. Jap. J. Pharmarol. 55: 469-475, 1991.
38. ZIMMERMAN, J. B., ROBERTSON, D. AND JACKSON, E. K : Angiotensin II-noradrenergic interactions in renovascular hypertensive rats. J. Clin. Invest. 80: 443-457, 1987.